Agile Collaboration Osseus's organically funded, privately held structure enables close surgeon partnerships and rapid development. This suggests opportunities for co-development deals, exclusive regional distribution, and fast onboarding of new spine implants and MIS systems.

ALIF Growth Pisces-SA standalone ALIF system received FDA 510(k) clearance and launched in 2023. Target spine centers with active ALIF programs and offer a bundled solution including implants, instruments, surgeon training, and in-OR support; pursue clinical data programs to drive adoption.

3D Printing Edge Aries-TC demonstrates additive manufacturing strength. Position Osseus for customizable or patient-specific interbody solutions and sell through centers needing tailored implants, providing design collaboration and regulatory/compliance support.

Growth Leadership New President Kelly Shelton joined in 2022, signaling scale-up and strategic growth. Leverage this to pursue expanded distribution partnerships, regional market expansion, and collaborations with GPOs and hospital networks.

Outcomes Focus Osseus emphasizes patient outcomes and surgeon partnerships. Develop outcomes data programs and surgeon education to support adoption, enabling cross-sell across Pisces-SA ALIF, Aries-TC, and future MIS spine devices.